Multiple Ground-Glass Opacities with Different Growth Rates in the Same Lobe of the Lung during the Follow-Up after the Resection of Pulmonary Adenocarcinoma: A Case Report (Short Report)


The patient, a 77-year-old male, underwent right middle lobectomy for adenocarcinoma of the lung, pT1aN0M0, in November 2007. In November 2008, chest CT revealed two ground-glass opacities (GGOs) in the right lower lobe. In October 2009, both of these GGOs had increased in size, and three new GGOs were found. In July 2011, all of the five GGOs had increased in size and three new GGOs were found yet again. Right lower lobe S6 segmentectomy was performed on September 6, 2011, and histopathological examination revealed eight pulmonary adenocarcinomas in the right S6; all of them classified as pl0, ly0, v0, pT1aN0M0. Among the eight lesions, the doubling times of five were measured during the follow-up course, and the mean doubling time was 402 days. The mean doubling time of the lesions showing high c-erbB2 expression was significantly lesser than that of the lesions showing low c-erbB2 expression (273 days vs. 488 days, p = 0.047). Despite being localized GGOs that had arisen in the same individual, it should be noted that the growth rate of the GGO lesions may vary according to the expression level of a molecular markers, and some GGO lesions may show rapid increase in size.

Share and Cite:

Yukawa, T. , Shimizu, K. , Hirami, Y. , Okita, R. , Saisho, S. , Maeda, A. , Yasuda, K. and Nakata, M. (2014) Multiple Ground-Glass Opacities with Different Growth Rates in the Same Lobe of the Lung during the Follow-Up after the Resection of Pulmonary Adenocarcinoma: A Case Report. Case Reports in Clinical Medicine, 3, 616-620. doi: 10.4236/crcm.2014.311132.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Ferguson, M.K., DeMeester, T.R., DesLauriers, J., Little, A.G., Piraux, M., et al. (1985) Diagnosis and Management of Synchronous Lung Cancers. The Journal of Thoracic and Cardiovascular Surgery, 89, 378-385.
[2] Verhagen, A.F., van de Wal, H.J., Cox, A.L. and Lacquet, L.K. (1989) Surgical Treatment of Multiple Primary Lung Cancers. The Journal of Thoracic and Cardiovascular Surgery, 37, 107-111.
[3] Lam, S., Macauley, C. and Palcic, B. (1993) Detection and Localization of Early Lung Cancer by Imaging Techniques. Chest, 103, 12-14.
[4] Woolner, L.B., Fontana, R.S. and Cortese, D.A. (1984) Roentogenographically Occult Lung Cancer; Pathologic Findings and Frequency of Multicentricity during a 10-Year Period. Mayo Clinic Proceedings, 59, 453-466.
[5] Van Rens, M.T., Zanen, P., Brutel de La Riviere, A., Elbers, H.R., van Swieten, H.A., et al. (2000) Survival in Synchronous versus Single Lung; Upstaging Better Reflects Prognosis. Chest, 118, 952-958.
[6] Nakata, M., Sawada, S., Yamashita, M., Saeki, H., Kurita, A., Takashima, S., et al. (2004) Surgical Treatment for Multiple Primary Adenocarcinoma of the Lung. Annals of Thoracic Surgery, 78, 1194-1199.
[7] Nakata, M., Saeki, H., Takata, I., Segawa,Y., Mogami, H., et al. (2002) Focal Ground-Glass Opacity Detected by Low-Dose Helical CT. Chest, 121, 1464-1467.
[8] Hiramatsu, M., Inagaki, T., Inagaki, T., Matsui, Y., Satoh, Y., Okumura, S., et al. (2008) Pulmonary Ground-Glass Opacity (GGO) Lesions-Large Size and a History of Lung Cancer Are Risk Factors for Growth. Journal of Thoracic Oncology, 3, 1245-1250.
[9] Aoki, T., Nakata, H., Watanabe, H., Nakamura, K., Kasai, T., Hashimoto, H., et al. (2000) Evolution of Peripheral Lung Adenocarcinomas: CT Findings Correlated with Histology and Tumor Doubling Time. American Journal of Roentgenology, 174, 763-768.
[10] Hasegawa, M., Sone, S., Takashima, S., Li, F., Yang, Z.G., Maruyama, Y., et al. (2000) Growth Rate of Small Lung Cancers Detected on Mass CT Screening. The British Journal of Radiology, 73, 1252-1259.
[11] Libby, D.M., Smith, J.P., Altorki, N.K., Pasmantier, M.W., Yankelevitz, D. and Henschke, C.I. (2004) Managing the Small Pulmonary Nodule Discovered by CT. Chest, 125, 1522-1529.
[12] Martini, N. and Melamed, M.R. (1975) Multiple Primary Lung Cancers. Journal of Thoracic and Cardiovascular Surgery, 70, 606-612.
[13] Dobashi, K., Sugio, K., Osaki, T., Oka, T. and Yasumoto, K. (1997) Micrometastatic p53-Positive Cells in the Lymph Nodes of Non-Small-Cell Lung Cancer: Prognostic Significance. Journal of Thoracic and Cardiovascular Surgery, 114, 339-346.
[14] Taga, S., Osaki, T., Ohgami, A., Imoto, H., Yoshimatsu, T., Yoshio, I., et al. (1997) Prognostic Value of the Immunohistochemical Detection of p16INK4 Expression in Non-Small Cell Lung Carcinoma. Cancer, 80, 389-395.<389::AID-CNCR6>3.0.CO;2-N
[15] Tsukamoto, S., Sugio, K., Sakada, T., Ushijima, C., Yamazaki, K. and Sugimachi, K. (2001) Reduced Expression of Cell-Cycle Regulator p27Kip1 Correlates with a Shortened Survival in Non-Small Cell Lung Cancer. Lung Cancer, 34, 83-90.
[16] Sugio, K., Ishida, T., Yokoyama, H., Inoue, T., Sugimachi, K. and Sasazuki, T. (1992) Ras Gene Mutations as a Prognostic Marker in Adenocarcinoma of the Human Lung without Lymph-Node Metastasis. Cancer Research, 52, 2903-2906.
[17] Osaki, T., Mitsudomi, T., Oyama, T., Nakanishi, R. and Yasumoto, K. (1995) Serum Level and Tissue Expression of c-erbB-2 Protein in Lung Adenocarcinoma. Chest, 108, 157-162.
[18] Mitsudomi, T., Hamajima, N., Ogawa, M. and Takahashi, T. (2000) Prognostic Significance of p53 Alterations in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis. Clinical Cancer Research, 6, 4055-4063.
[19] Otterson, G.A., Kratzke, R.A., Coxon, A., Kim, Y.M. and Kaye, F.J. (1994) Absence of p16INK4 Protein Is Restricted to the Subset of Lung Cancer Lines that Retains Wildtype RB. Oncogene, 9, 3375-3378.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.